Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
The ability of the bone marrow (BM) to generate copious amounts of blood cells required on a daily basis depends on a highly orchestrated process of proliferation and differentiation of hematopoietic stem and progenitor cells (HSPCs). This process can be rapidly adapted under stress conditions, such as infections, to meet the specific cellular needs of the immune response and the ensuing physiological changes. This requires a tight regulation in order to prevent either hematopoietic failure or transformation. Although adaptation to bacterial infections or systemic inflammation has been studied and reviewed in depth, specific alterations of hematopoiesis to viral infections have received less attention so far. Viruses constantly pose a significant health risk and demand an adequate, balanced response from our immune system, which also affects the BM. In fact, both the virus itself and the ensuing immune response can have a tremendous impact on the hematopoietic process. On one hand, this can be beneficial: it helps to boost the cellular response of the body to resolve the viral infection. But on the other hand, when the virus and the resulting antiviral response persist, the inflammatory feedback to the hematopoietic system will become chronic, which can be detrimental for a balanced BM output. Chronic viral infections frequently have clinical manifestations at the level of blood cell formation, and we summarize which viruses can lead to BM pathologies, like aplastic anemia, pancytopenia, hemophagocytic lymphohistiocytosis, lymphoproliferative disorders, and malignancies. Regarding the underlying mechanisms, we address specific effects of acute and chronic viral infections on blood cell production. As such, we distinguish four different levels in which this can occur: (1) direct viral infection of HSPCs, (2) viral recognition by HSPCs, (3) indirect effects on HSPCs by inflammatory mediators, and (4) the role of the BM microenvironment on hematopoiesis upon virus infection. In conclusion, this review provides a comprehensive overview on how viral infections can affect the formation of new blood cells, aiming to advance our understanding of the underlying cellular and molecular mechanisms to improve the treatment of BM failure in patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Janeway, C. A., & Medzhitov, R. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.083001.084359 · Cited by 8,394 · cited 1×
“in Stress-induced Hematopoiesis Pathogen recognition receptors are receptors that detect pathogen-associated molecular patterns (PAMPs) within the body (48, 49).”
BackgroundThe bone marrow niche for haematopoietic stem cells
Morrison, S. J., & Scadden, D. T. (2014) · Nature · doi:10.1038/nature12984 · Cited by 2,451 · cited 9×
“HSCs only occasionally give rise to new progenitors and are instead protected and nurtured by a complex microenvironment of resident hematopoietic and non-hematopoietic cells (3).”
BackgroundInfluentialIFNα activates dormant haematopoietic stem cells in vivo
Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A. (2009) · Nature · doi:10.1038/nature07815 · Cited by 1,368
Fundamental properties of unperturbed haematopoiesis from stem cells in vivo
Busch, K., Klapproth, K., Barile, M., Flossdorf, M., Holland-Letz, T., Schlenner, S. M., Reth, M., Höfer, T., & Rodewald, H.-R. (2015) · Nature · doi:10.1038/nature14242 · Cited by 769 · cited 9×
“mechanisms act via direct effects on HSPCs: (1) direct viral infection or (2) viral recognition by HSPCs.”
BackgroundInfluentialExit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Walter, D., Lier, A., Geiselhart, A., Thalheimer, F. B., Huntscha, S., Sobotta, M. C., Moehrle, B., Brocks, D., Bayindir, I., Kaschutnig, P., et al. (2015) · Nature · doi:10.1038/nature14131 · Cited by 619
Haas, S., Hansson, J., Klimmeck, D., Loeffler, D., Velten, L., Uckelmann, H., Wurzer, S., Prendergast, Á. M., Schnell, A., Hexel, K., et al. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.07.007 · Cited by 471 · cited 1×
“Again, chronic exposure to polyI:C triggered exhaustion of these stem-cell-like megakaryocyte progenitors and a delayed repletion of platelet counts (79).”
BackgroundPietras, E. M., Lakshminarasimhan, R., Techner, J.-M., Fong, S., Flach, J., Binnewies, M., & Passegué, E. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131043 · Cited by 323 · cited 2×
“Type I IFN-exposed HSCs with reestablished quiescence are not fully functional but are also largely protected from the killing effects of IFNs unless forced back into the cell cycle due to culture, transplantation, or myeloablative treatment, at which point they activate a p53-dependent proapoptotic gene program (75).”
BackgroundImpact of interferon-γ on hematopoiesis
de Bruin, A. M., Voermans, C., & Nolte, M. A. (2014) · Blood · doi:10.1182/blood-2014-04-568451 · Cited by 215 · cited 5×
“Second, the fact that a certain virus can lead to different pathological manifestations in different individuals points to a genetic basis for aberrant immune activation in BM failure, as suggested before (19, 25).”
BackgroundInfluentialSelf-citationMirantes, C., Passegué, E., & Pietras, E. M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.017 · Cited by 211
Libregts, S. F., Gutiérrez, L., de Bruin, A. M., Wensveen, F. M., Papadopoulos, P., van Ijcken, W., Özgür, Z., Philipsen, S., & Nolte, M. A. (2011) · Blood · doi:10.1182/blood-2010-10-315218 · Cited by 204 · cited 1×
“IFNγ triggering on HSPCs enhances monocyte formation, but this is at the expense of the production of neutrophilic (83) and eosinophilic granulocytes (84), B cells (85, 86), and erythrocytes (87, 88).”
BackgroundSelf-citationIFNγ induces monopoiesis and inhibits neutrophil development during inflammation
de Bruin, A. M., Libregts, S. F., Valkhof, M., Boon, L., Touw, I. P., & Nolte, M. A. (2012) · Blood · doi:10.1182/blood-2011-07-367706 · Cited by 146
Self-citationWang, C. Q., Udupa, K. B., & Lipschitz, D. A. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620116 · Cited by 107
Beaupere, C., Garcia, M., Larghero, J., Fève, B., Capeau, J., & Lagathu, C. (2015) · Aging Cell · doi:10.1111/acel.12308 · Cited by 85
Cited by
The Polygenic and Monogenic Basis of Blood Traits and Diseases
Vuckovic, D., Bao, E. L., Akbari, P., Lareau, C. A., Mousas, A., Jiang, T., Chen, M.-H., Raffield, L. M., Tardaguila, M., Huffman, J. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.008 · Cited by 671
Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A., Barba, P., Bruno, B., Benjamin, R., Carrabba, M. G., Chabannon, C., et al. (2023) · Blood · doi:10.1182/blood.2023020578 · Cited by 358
Biavasco, R., Lettera, E., Giannetti, K., Gilioli, D., Beretta, S., Conti, A., Scala, S., Cesana, D., Gallina, P., Norelli, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24876-1 · Cited by 47
Pascutti, M. F., Geerman, S., Collins, N., Brasser, G., Nota, B., Stark, R., Behr, F., Oja, A., Slot, E., Panagioti, E., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201848003 · Cited by 37
Self-citation
Metadata
- Authors
- Pascutti, M. F., Erkelens, M. N., & Nolte, M. A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2016-09-16
- Volume
- 7
- Pages
- 364-364
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2520819272
- Cited by
- 166
- References
- 13
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.